Bangladesh's Beximco signs COVID-19 vaccine deal with India's Serum Institute

United States News News

Bangladesh's Beximco signs COVID-19 vaccine deal with India's Serum Institute
United States Latest News,United States Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

Bangladesh's Beximco Pharmaceuticals is investing in the Serum Institute of India (SII) to ensure Dhaka gets priority access to COVID-19 vaccines being developed by the Indian drug manufacturer, the company said on Friday.

DHAKA - Bangladesh’s Beximco Pharmaceuticals is investing in the Serum Institute of India to ensure Dhaka gets priority access to COVID-19 vaccines being developed by the Indian drug manufacturer, the company said on Friday.

SII has partnered with AstraZeneca, the Gates Foundation and the Gavi vaccine alliance to produce more than a billion doses of a COVID-19 vaccine for global supply. “This landmark agreement reflects the deep-rooted desire for collaboration between the two countries and as representatives of the two nations, between us we can go a long way towards helping to mitigate the health crisis caused by the COVID-19 pandemic,” the heads of both companies said in the statement.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

COVID-19 Vaccine May Pit Science Against PoliticsCOVID-19 Vaccine May Pit Science Against PoliticsNew vaccines usually take years to get the approval of the Food and Drug Administration. But the Trump administration suggests the FDA may greenlight a coronavirus vaccine by the end of the year.
Read more »

EU pays 336 million euros for doses of AstraZeneca's potential COVID-19 vaccineEU pays 336 million euros for doses of AstraZeneca's potential COVID-19 vaccineThe European Commission has paid 336 million euros ($396 million) to secure at least 300 million doses of the potential COVID-1 vaccine being developed by British drug maker AstraZeneca , a spokesman said on Thursday.
Read more »

Japan, eyeing Olympics, lines up half-billion doses of COVID-19 vaccineJapan, eyeing Olympics, lines up half-billion doses of COVID-19 vaccineJapan is making an aggressive move to grab enough coronavirus vaccine to inoculate its population four times over, a push the government hopes will instil confidence that it can host a delayed summer Olympics next year.
Read more »

Here\u2019s Why You Shouldn\u2019t Skip Your ImmunizationsHere\u2019s Why You Shouldn\u2019t Skip Your ImmunizationsCOVID19 has us postponing a lot of things: immunizations, including the flu vaccine, shouldn't be one of them.vaccines
Read more »



Render Time: 2025-02-23 04:24:44